A recent study conducted across nine Iowa hospitals has shown promising results in reducing postoperative opioid ...

Scientists at Duke University have developed a new experimental drug that may offer strong pain relief without the risks ...

Eli Lilly has reached a deal to acquire SiteOne Therapeutics that would give it control of a non-opioid pain drug that would ...

Eli Lilly will buy privately held SiteOne Therapeutics in a deal worth as much as $1 billion, the companies said on Tuesday, ...

Dasgupta spoke with 97.9 The Hill’s Brighton McConnell about recent data from the CDC and his lab’s efforts to address the ...

The acquisition expands Lilly’s pain pipeline with a slate of drugs targeting ion channel proteins like NaV1.7 and NaV1.8.

Researchers from the University of Missouri School of Medicine have shed light on what populations are more likely to be ...

A new experimental painkiller has shown promise in dulling or eliminating pain without the addictive qualities exhibited by ...

Eli Lilly acquires SiteOne Therapeutics for up to $1B, signaling potential uptick in Big Pharma deals and focus on non-opioid ...